Unexpected Pathology in a Post-Transplantation Protocol Biopsy
PathPointers is a new type of blog post that will highlight important everyday teaching points when reviewing kidney histology. These blog posts will be brief and easy-to-read, using real clinical images to demonstrate various biopsy findings. In addition to AJKD Social Media Editor, Timothy Yau, and Education Editor, Stanley Goldfarb, these posts are also reviewed and edited by Pathology Editor, Matt Palmer.
A 54-year-old male kidney transplant recipient underwent a protocol biopsy 3 months after transplantation. His graft function was stable and he had no proteinuria. The biopsy revealed no evidence of T-cell or antibody mediated injury. However, one glomerulus revealed a segmental scar (Figure 1); moderate arteriolar hyalinosis was also observed.
The patient’s end-stage renal disease (ESRD) was not due to focal segmental glomerulosclerosis (FSGS), but rather was due to granulomatous polyangiitis. With this additional information, the biopsy was re-examined and revealed a fibrocellular crescent (Figure 2).
This case illustrates the clinical utility of protocol biopsy to reveal unexpected pathology at a stage when it may not be clinically manifest. This patient had stable graft function and no proteinuria, yet a fibrocellular crescent was seen and may warrant intervention in this setting for recurrent polyangiitis.
In a published pooled analysis, recurrence of ANCA-associated vasculitis such as granulomatous polyangiitis occurred in 17.3% of patients. Recurrence consists of renal-limited disease in 60% of cases, and appears to be independent of the presence of ANCA antibodies at the time of transplantation. Graft function recovers in most patients after intensified immunosuppression. The overall graft survival in these patients with recurrent vasculitis was 78% at 3 years and 65% at 10 years.
– Post prepared by Parmjeet Randhawa, AJKDBlog Contributor.
Leave a Reply